The inventions described herein relate to the technical field of medical methods and devices known as Transcatheter Aortic Valve Implantation (TAVI) or Transcatheter Aortic Valve Replacements (TAVR). Specifically, the present inventions relate to methods and devices for improving the implantation of transcatheter aortic replacement valves.
TAVI is an alternative method to traditional valve replacement. Traditionally, open-heart surgery with cardiopulmonary bypass is required to replace an aortic valve, wherein a patient's native aortic valve is surgically removed and replaced with an artificial mechanical valve. While mechanical valves were popular in the past, today about 70% of replacement valves are biological valves using biological tissue from other sources. The increased use of biological valves has increased the need for better, more effective methods of biological replacement valve implantation.
TAVI uses minimally invasive methods to replace a native aortic valve by injecting a transcatheter biological replacement valve over the native aortic valve without surgically removing the native aortic valve. A transcatheter aortic replacement valve is generally structured by a stent-like metal frame, which is collapsible and is either self-expandable or expanded by a balloon catheter. The metal frame is sutured to and supports tissue leaflets, typically bovine or porcine tissue, which act as biological valve replacements. During implantation of the replacement valve, a catheter is inserted into the aorta transfemorally, transapically, or transaortically. The catheter contains a compressed replacement valve and delivers the compressed replacement valve to the aortic valve, where the replacement valve is positioned within the aortic valve and released. The released replacement valve expands within the native aortic valve and radial pressure from the expandable metal frame situates the replacement valve within the native aortic valve by folding the leaflets against the aortic wall. Some calcification of the aortic valve leaflets is necessary to provide stability for the replacement valve and to hold the replacement valve in place.
Valvuloplasty is used to widen a stenotic aortic valve using a balloon catheter. The TAVI replacement valve's wire-mesh metal frame is positioned around the balloon catheter such that the balloon catheter simultaneously widens both the aortic valve and TAVI replacement valve for implantation. Therefore, correct placement of the replacement valve within the native aortic valve is crucial to long-term success of the replacement valve.
Two medical device companies have FDA-approved TAVI devices on the market. Edwards Lifesciences first introduced the SAPIEN THV, approved on Nov. 2, 2011, and has since introduced the approved SAPIEN 3 and SAPIEN XT. Medtronic produces a second type of TAVI replacement valve, the CoreValve, which was first approved on Jan. 17, 2014. As is typical of TAVI replacement valves, the SAPIEN devices and the CoreValve primarily use radial pressure to secure the replacement valve within the native valve without use of additional sutures or connections.
Based on data collected from the FDA Manufacturer and User Facility Device Experience (MAUDE) database from February 2014 to December 2015, the Edwards PARTNER Trial, and other published studies the implantation of current TAVI replacement valves requires further improvement to reduce complications and improve patient outcome. Nearly 20 percent of the FDA MAUDE complaints analyzed involved replacement valve implanting and positioning errors, including misplacement and embolization, incomplete inflation, or dislodgement of the replacement valve after implantation. Varying severities of paravalvular leaks often follow improper implantation of replacement valves in the annulus. Incomplete expansion of the replacement valve within the annulus allows high pressure blood to leak between the outer surface of replacement valve and the annulus. Depending on the patient's health, a second or third replacement valve may have to be inserted. Duplicating such procedures can increase the risk of further complications.
Further, conductive issues with the electrical conduction system of the heart can arise due to excessive radial pressure applied by the replacement valve to calcium deposits on the aortic leaflets sandwiched between the aorta and replacement valve. As shown in
Traditional TAVI can exacerbate cardiac conduction system interruption in patients with TAVI replacement valves. Aortic stenosis, or the narrowing of the aortic valve 102, can be congenital or acquired and occurs when at least two of the three aortic valve leaflets 104 begin to, or are fully, fused together.
Calcium build-up on the aortic valve leaflets can also cause stenosis. Atherosclerosis along the aortic surface of the valve calcifies subsequent to aortic valvular osteoblast differentiation to create a calcific area. In time, the calcific area can grow to between 1.0 cm and 1.7 cm in diameter. Calcific stenosis occurs when enough calcium has accumulated along the surface of the aortic valve leaflets to impede the flow of blood out of the left ventricle. If a patient has a calcific aortic valve, the current TAVI procedure and corresponding replacement valves can cause further complications during implantation. Since the TAVI replacement valves currently on the market push the aortic valves upward and outward, such that the native aortic valve forms a coaxial layer between the aorta and replacement valve, calcium build up can increase the radial pressure applied to the AV node, Bundle of His, and Purkinje fibers.
Heavily calcified aortic valves cannot be dilated evenly during valvuloplasty due to the uneven size and distribution of calcium deposits on calcific aortic valves. Uneven dilation of the native aortic valve alone can result in dislodgement of the TAVI replacement valve or paravalvular leaks. Coupled with unevenly shaped and distributed calcium deposits, uneven dilation can cause aortic dissection with crashing of the Bundle of His or left Bundle due to the radial pressure of the TAVI replacement valve pushing calcium deposits on the native aortic valve into sensitive areas of the cardiac conductive system. Resulting cardiac conditions may include Left Bundle Branch Block (LBBB), Right Bundle Branch Block (RBBB), and Atrioventricular Block (AVB). Patients who undergo the TAVI procedure and develop arrhythmias or one of the aforementioned blocks often require permanent pacemakers to maintain consistent and regular heart rates. By relieving the restriction of blood flow caused by aortic stenosis, the current TAVI method and replacement valves may cause other critical cardiac issues for patients without any prior history of arrhythmias or conductive conditions.
The biggest consequence of current TAVI replacement valve issues is the additional medical procedures and equipment needed to counteract conduction problems. In nearly 70% of patients currently receiving a TAVI replacement valve, an artificial pacemaker must be inserted to rectify conduction issues caused largely by calcium deposits on the native aortic valve crushing the cardiac conductive system during the implantation of the TAVI replacement valve.
The inventions and embodiments described herein solve current issues with TAVI procedures by largely removing calcium deposits from the aortic valve.
The present invention solves the problem of improper implantation of current TAVI replacement valves by disclosing a method and device for removing a significant portion of calcific deposits on a native aortic valve to lower conductive interference, while preserving enough calcific deposits around the circumference of the native aortic valve to aid in the stabilization of the TAVI replacement once implanted.
An embodiment of the process of removing calcific deposits on the native aortic valve includes:
inserting a device through a native aortic valve, wherein the device has a filter umbrella attached to a punch having a male element and a female element separable along a plane perpendicular to connection;
positioning the punch within the native aortic valve, wherein the male element and female element are fusiform;
positioning the filter umbrella in an aorta down-stream of blood flow through the native aortic valve, such that the filter umbrella allows blood to pass beyond the aorta and catches dislodged calcium particles;
opening the punch within the native aortic valve such that aortic valve leaflets are positioned between the male element and the female element;
closing the punch over the aortic valve leaflets so that the male element applies force to a superior surface of the aortic valve leaflets and the female element applies force to an inferior surface of the aortic valve leaflets;
removing calcium deposits from center of native aortic valve by perforation; and
leaving a ring of calcium deposits along the circumference of the native aortic valve.
An embodiment of the device used to remove calcium from the aortic valve includes:
a tip attached to a distal end of a primary tube having a circumference large enough to at least allow a guide wire to pass through;
a self-expandable stent covered with a perforated mesh, with the self-expandable stent attached to a distal end of a secondary tube positioned coaxially around an outer surface of the primary tube;
a punch system, having a male element, with a proximal end connected to a tertiary tube, and a female element, having a proximal end connected to a quaternary tube, which is positioned coaxially around an outer surface of the tertiary tube, which is positioned coaxially around an outer surface of the primary tube;
a punch control element connected at a distal end to the quaternary tube, having a punch dial attached to a proximal end of a reversely-threaded punch spindle, a punch receptacle with an inner cylindrical area open at a proximal end and threaded to accept the punch spindle, wherein the punch receptacle contain a centered coaxial hole to allow the tertiary tube to pass through and connect to the punch spindle, and the punch spindle and punch dial contain a centered coaxial hole to allow the primary tube to pass through, and wherein the punch dial is configured to turn either clockwise or counterclockwise to raise or depress the punch spindle within the inner cylindrical area of the punch receptacle, which raises and lowers the male element via the tertiary tube relative to the female element; and
a stent control element, having a stent dial attached to a proximal end of a reversely-threaded stent spindle, a stent receptacle with an inner cylindrical area open at a proximal end and threaded to accept the stent spindle, wherein the stent receptacle contains a centered coaxial hole to allow the primary tube to pass through and attach to the stent spindle, and wherein the stent dial is configured to turn either clockwise or counterclockwise to raise or depress the stent spindle within the inner cylindrical area of the stent receptacle, which in turn raises and lowers the self-expandable stent covered with perforated mesh relative to the tip.
Another embodiment of the device for removing calcium deposits from the aortic valve includes:
a punch system, having a male element with a proximal end connected to a distal end of a primary tube and a conically-shaped distal end, a female element, having a proximal end connected to a secondary tube, which is positioned coaxially around an outer surface of the primary tube, which is positioned coaxially around an outer surface of the primary tube;
a self-expandable stent covered with a perforated mesh, with the self-expandable stent attached to a distal end of a tertiary tube positioned coaxially around an outer surface of the secondary tube;
a stent sheath attached to a distal end of a quaternary tube positioned coaxially around an outer surface of the tertiary tube;
a stent control element, having a stent dial attached to a proximal end of a reversely-threaded stent spindle, a stent receptacle with an inner cylindrical area open at a proximal end and threaded to accept the stent spindle, wherein a distal end of the stent receptacle is attached to the proximal ends of the secondary and quaternary tubes and contains a centered coaxial hole to allow the tertiary tube to pass through and connect to the stent spindle, and the stent spindle and stent dial contain a centered coaxial hole to allow the primary tube to pass through, and wherein the stent dial is configured to turn either clockwise or counterclockwise to raise or depress the punch spindle within the inner cylindrical area of the stent receptacle, which in turn raises the stent out of the stent sheath allowing expansion of the stent and lowers the stent into the stent sheath whereby a circumferential edge of the stent sheath causes the stent to contract as the stent spindle is raised; and
a punch control element, having a punch dial attached to a proximal end of a reversely-threaded punch spindle, a punch receptacle with an inner cylindrical area open at a proximal end and threaded to accept the punch spindle, wherein the punch receptacle contains a centered coaxial hole to allow the primary tube to pass through and attach to the punch spindle, and wherein the punch dial is configured to turn either clockwise or counterclockwise to raise or depress the punch spindle within the inner cylindrical area of the punch receptacle, which raises and lowers the male element via the primary tube relative to the female element.
Yet another embodiment of the device for removing calcium deposits from a valve includes:
a punch system, having a male element with a proximal end connected to a distal end of a primary tube and a conically-shaped distal end, a female element, having a proximal end connected to a secondary tube, which is positioned coaxially around an outer surface of the primary tube, which is positioned coaxially around an outer surface of the primary tube;
a punch control element attached to the primary and secondary tubes and end opposite to the punch element, wherein the punch control element is configured to move the male element in relation to the female element.
Other embodiments of these processes and devices are described herein. These embodiments are not exclusive of the only possible embodiments. A further understanding of the structural, functional, and advantageous aspects of the disclosure can be realized by reference to the following detailed description and drawings.
Figures accompanying the specification show and describe the inventions, as follows:
Various embodiments and aspects of the disclosure are described with reference to details discussed below. The following descriptions and referenced drawings are illustrative of the disclosure and are not to be construed as limiting the disclosure. The drawings are not necessarily to scale. Numerous specific details are described to provide a thorough understanding of various embodiments of the present disclosure. However, in certain instances, well-known or conventional details are not described in order to provide a concise discussion of embodiments of the present disclosure.
As used herein, spatial and relative terms such as “proximal” and “distal” are relative to a user of the methods or devices described herein, unless otherwise stated. For example, a distal end of a tube is the end farthest from a user, whereas a proximal end of the same tube is the end closest to the user.
A preferred embodiment for the method for improving transcatheter aortic valve implantation is shown in
A next step is positioning the punch 502 within the native aortic valve 526, wherein the male element 508 and female element 514 are fusiform, as shown in
A further step includes opening the punch 502 within the native aortic valve 526 such that aortic valve leaflets 528 are positioned between the cutting edge 510 of the male element 508 and the cutting edge 516 of the female element 514.
A next step includes closing the punch 502 over the aortic valve leaflets 528 so that the male element 508 applies force along the cutting edge 510 to a superior surface 532 of the aortic valve leaflets 528 and the female element 514 applies force along the cutting edge 516 to an inferior surface 530 of the aortic valve leaflets 528.
Another step includes perforating the native aortic valve 526 via the punch 502 to remove calcium deposits from the native aortic valve.
The final step includes leaving a ring of calcium deposits 534, as shown in
Another embodiment for the method for improving transcatheter aortic valve implantation is shown in
The arrangement of elements of the device must change due to direction of bloodflow when the device is inserted transaortically or transfemorally, as compared to transapically. A suitable embodiment of a device 400 for use in inserting via the aorta or femoral artery is show in
A next step is positioning the punch 206 within the native aortic valve, wherein the male element and female elements are fusiform. The male 218 and female 220 elements are fusiform during insertion and positioning of the punch 206 in the native aortic valve to minimize the detachment of calcium deposits from the aortic leaflets before the engagement of the filter umbrella 212 in the aorta. Otherwise, cutting edges of the male and female elements 223 and 225 may inadvertently catch on and dislodge calcium from the native aortic valve, thereby increasing the risk of an embolism.
The method then includes positioning the filter umbrella 212 in an aorta down-stream of the aortic valve. The filter umbrella is disengaged, or closed, during insertion to prevent any accidental damage to surrounding tissue or dislodgement of calcium deposits, similar to the punch 206. This is achievable through a slidable hood 214, as shown in
A further step is engaging the filter umbrella 212 such that the filter umbrella 212 allows blood to pass beyond the aorta, but catches dislodged calcium particles to prevent such particles from passing through the rest of the body via the aorta. This step is achievable via the slidable hood 214 or 434 sliding over the filter umbrella 212 or 424 such that the filter umbrella 212 or 424 is allowed to expand circumferentially to encompass the circumference of the aorta.
Another step includes opening the punch 206 within the native aortic valve 221 such that aortic valve leaflets 241 are positioned between the cutting edge 223 of the male element 218 and the cutting edge 225 of the female element 220.
A next step includes closing the punch 206 over the aortic valve leaflets 241 so that the male element 218 applies force along the cutting edge 223 to a superior surface 242 of the aortic valve leaflets 241 and the female element 220 applies force along the cutting edge 225 to an inferior surface 244 of the aortic valve leaflets 241.
Another step includes perforating the native aortic valve 221 via the punch 206 to remove calcium deposits from the native aortic valve.
The final step includes leaving a ring of calcium deposits 246 along the circumference of the native aortic valve 221. The perforation of the native aortic valve 246 should leave a circumferential ring of the remaining tissue of the native aortic valve with a preferable length of 2-3 millimeters. Further, the perforation is preferably centered such that the resulting circumferential ring of tissue is uniform in radial length. As previously explained, a semi-rigid ring composed of the remaining aortic heart is useful in stabilizing any TAVI replacement valve during and after insertion. Additionally, less radial pressure is ultimately placed on the heart conduction system as the majority of the calcium deposits are removed from the native aortic valve. Further, the chance of paravalvular leaks is reduced, as the shortened aortic leaflets make insertion of replacement valves easier and more successful.
There are multiple embodiments for removing calcium deposits from aortic valves. A preferred embodiment of a device 500 for improving transcatheter aortic valve implantation is shown in
The punch 502, primary tube 512, and punch control element 504 can also have a continuous, coaxially-centered hole through each enumerated element such that the device 500 can be run over a guide wire.
The punch 502 can be made of medical grade plastics or metals, as typically used in similar invasive devices. At least the male element 508 has a cutting edge 510 used to perforate an aortic leaflet or other biological tissue. The cutting edge 510 is typically located around a circumference of the male element 508, and can be shaped in different manners, including, but not limited to, a uniform circle about a plane, a plurality of teeth in sine wave, square, triangle, or sawtooth pattern, or similar orientation.
The female element 514 can also have a cutting element 516 shaped to accept the pattern of the male cutting element 510 to allow the male 508 and female element to form a fusiform punch 502 during insertion of the device 500 through the aortic valve without snaring or otherwise inadvertently damaging tissue during insertion or positioning of the device. The female element 514 may likewise contain a receptacle for accepting the male cutting element 510.
The tip 506 is conically shaped to pierce at least the heart at the apex and allow entry of the device 500 into the left ventricle and aortic valve. The tip 506 could also be used to pierce arterial walls, for example the aorta or femoral artery.
The primary 512 and secondary 518 tubes can be made from medical grade plastics, metals, or combinations thereof. While the secondary tube 518 must be hollow with a diameter large enough for the primary tube 512 to slide through, the primary tube 512 need not be hollow. There is no set length for either the primary tube 512 or the secondary tube 518. However, the primary tube 512 is necessarily longer that the secondary tube 518, and both should be long enough to comfortably allow the insertion and positioning of the punch 502 in the aortic valve, while simultaneously allowing a user to operate the punch control element 504.
The punch control element 504 can be made from medical grade plastics, metals, or combinations thereof. The punch spindle 522 is preferably reversely-threaded and the inner cylindrical area 525 is preferably threaded to accept the reversely-threaded punch spindle 522. However, other interactions are possible, for example, where the punch spindle 522 slidably engages the cylindrical area 525 and frictional forces from a rubber ring or equivalent maintain punch spindle position within the cylindrical area. The punch dial 524 need not be of any specific shape or size, but only sized and shaped to allow a user to manipulate the punch 502 via the primary tube 512, punch spindle 522, and punch control element 504, generally.
Another embodiment of a device 600 for improving transcatheter aortic valve implantation is shown in
Force applied to the second lever 630 in a direction toward the first lever 628 causes the second lever to pivot at the external fulcrum point 622. The pivot motion at the external fulcrum point 622 in turn causes the second lever 630 to pivot at the internal fulcrum point 632, where the second lever is attached to the second lever housing 620. The pivoting at the internal fulcrum point 632 causes the second lever housing 620 to pull directly away from the first lever housing 618, thereby stretching the spring 626 and pulling the primary tube 612 in the same direction until the male element 608 mates with the female element 614 preventing further sliding. The spring housing 624 is also pulled in the same direction causing the spring housing to slide within the first lever housing 620. As force on the second lever 630 is reduced, the elastic force from the spring 624 pulls the second lever housing 620 back towards the first lever housing 618, causing the spring housing 624 to slide farther inside the first lever housing 618 and the male element 608 to decouple from the female element 614.
The punch 602, primary tube 612, and punch control element 604 can also have a continuous, coaxially-centered hole through each enumerated element such that the device 600 can be run over a guide wire.
The punch 602 can be made of medical grade plastics or metals, as typically used in similar invasive devices. At least the male element 608 has a cutting edge 610 used to perforate an aortic leaflet or other biological tissue. The cutting edge 610 is typically located around a circumference of the male element 608, and can be shaped in different manners, including, but not limited to, a uniform circle about a plane, a plurality of teeth in sine wave, square, triangle, or sawtooth pattern, or similar orientation.
The female element 614 can also have a cutting element 615 shaped to accepted the pattern of the male cutting element 610 to allow a fusiform punch 602 during insert of the device 600 through the body and heart and into the aortic valve without snaring or otherwise inadvertently damaging tissue during insertion or positioning of the device. The female element 614 may likewise contain a receptacle for accepting the male cutting edge 610.
The tip 606 is conically shaped to pierce at least the heart at the apex and allow entry of the device 600 into the left ventricle and aortic valve. The tip 606 could also be used to pierce arterial walls, for example the aorta or femoral artery.
The primary 612 and secondary 616 tubes can be made from medical grade plastics, metals, or combinations thereof. While the secondary tube 616 must be hollow with a diameter large enough for the primary tube 612 to slide through, the primary tube 612 need not be hollow. There is no set length for either the primary tube 612 or the secondary tube 616. However, the primary tube 612 is necessarily longer that the secondary tube 616, and both should be long enough to comfortably allow the insertion and positioning of the punch 602 in the aortic valve, while simultaneously allowing a user to operate the punch control element 604.
The punch control element 604 can be made from medical grade plastics, metals, or combinations thereof. The first lever 628 and second lever 630 do not have a set length, shape or size, but should be long enough for a user to comfortably grasp and operate the levers 628 and 630 in one hand. The spring housing 624 should be of an appropriate diameter to allow the spring 626 to easily expand and contract during use, while simultaneously preventing the spring from bowing or bending substantially outward from the length of the spring.
The embodiment of the device 600 shown in
Another embodiment of a device 200 is shown in
A punch 206 has a male element 218 connected at a distal end to a proximal end of the secondary tube 216 and connected at a proximal end to a distal end of a tertiary tube 219, which is positioned coaxially around an outer surface of the secondary tube 216, and a female element 220 connected at a proximal end to a distal end of a quaternary tube 222, which is positioned coaxially around an outer surface of the tertiary tube 219.
The device 200 further includes a punch control element 204, having a punch dial 232 attached to a proximal end of a punch spindle 228, and a punch receptacle 226 with an inner cylindrical area 224 open at a proximal end to accept the punch spindle, wherein the punch receptacle is connected to a proximal end of the quaternary tube 222 and contains a centered coaxial hole to allow the tertiary tube 219, secondary tube 216, and primary tube 217 to pass through. The tertiary tube 219 attaches to the punch spindle 228 at a proximal end.
The punch dial 232 is configured to turn either clockwise or counterclockwise to raise or depress the punch spindle 228 within the inner cylindrical area 224 of the punch receptacle 226, which raises and lowers the male element 218 via the tertiary tube 217 relative to the female element 220. As shown in
The device 200 further includes a stent control element 202, having a stent dial 240 attached to a proximal end of a stent spindle 238, and stent receptacle 234 with an inner cylindrical area 236 open at a proximal end to accept the stent spindle, wherein the stent receptacle connects to a distal end of the secondary tube 216 which contains a centered coaxial hole to allow the primary tube 217 to pass through. The primary tube 217 attaches at a proximal end to the stent spindle 238.
The stent dial 240 is configured to turn either clockwise or counterclockwise to raise or depress the stent spindle 238 within the inner cylindrical area 236 of the stent receptacle 234, which in turn slides the stent sheath 214 relative to stent 213.
As shown in
The punch 208 can be made of medical grade plastics or metals, as typically used in similar invasive devices. At least the male element 218 has a cutting edge 223 used to perforate an aortic leaflet or other biological tissue, as shown in
The female element 220 can also have a cutting element 225 patterned to accepted the pattern of the male cutting element 223 to allow a fusiform punch 208 during insert of the device 200 through the aortic valve without snaring or otherwise inadvertently damaging tissue during insertion or positioning of the device, as shown as
The tip 210 may be conically shaped to pierce at least the heart at the apex and allow entry of the device 200 into the left ventricle and aortic valve. Alternatively, the tip 210 may be flattened with sufficiently rounded edges to prevent damage to tissue during insertion or removal of the device from the body.
The primary 217, secondary 216, tertiary 219, and quaternary 222 tubes can be made from medical grade plastics, metals, or combinations thereof. There is no set length for any of the tubes 216, 217, 219, and 222. However, the primary tube 217 is necessarily longer that the secondary tube 216, and the tertiary tube 219 is necessarily longer than the quaternary tube 222. All four tubes 216, 217, 219, and 222 should be long enough to comfortably allow the insertion and positioning of the stent system 208 and punch 206 in the aorta and aortic valve, while simultaneously allowing a user to operate the punch control element 204 and the stent control element 202.
The punch control element 204 can be made from medical grade plastics, metals, or combinations thereof. The punch spindle 228 is preferably reversely-threaded and the inner cylindrical area 224 of the punch receptacle 226 is preferably threaded to accept and secure the reversely-threaded punch spindle.
The stent control element 202 can be made from medical grade plastics, metals, or combinations thereof. The stent spindle 238 is preferably reversely-threaded and the inner cylindrical area 236 of the stent spindle 234 is preferably threaded to accept and secure the reversely-threaded punch spindle.
The device 200 may further include a motor assembly 270, as shown in
Another embodiment of a device 400 is show in
A self-expandable stent 426 covered with a perforated mesh 428 forms a stent umbrella 424. The stent 426 is attached to a distal end of a tertiary tube 430 positioned coaxially around an outer surface of the secondary tube. A stent sheath 434 is attached to a distal end of a quaternary tube 432, which is positioned coaxially around an outer surface of the tertiary tube 430. The stent sheath 434 is open at a distal end and positioned coaxially around the tertiary tube 430 with enough space between the stent sheath and tertiary tube to allow the stent 426, perforated mesh 428, and stent umbrella 424 to be slidably positionable between the stent sheath and tertiary tube.
A stent control element 406 has a stent dial 442 attached to a proximal end of a reversely-threaded stent spindle 440, a stent receptacle 436 with an inner cylindrical area 438 open at a proximal end and threaded to accept the stent spindle, wherein a distal end of the stent receptacle is attached to the proximal ends of the tertiary and quaternary tubes 430 and 432, and contains a centered coaxial hole to allow the tertiary tube to pass through and connect to the stent spindle, and the stent spindle and stent dial contain a centered coaxial hole to allow the primary and secondary tube 416 and 422 to pass through. The stent dial 442 is configured to turn either clockwise or counterclockwise to raise or depress the stent spindle 440 within the inner cylindrical area 438 of the stent receptacle 436, which in turn pushes the stent 426 out of the stent sheath 434 allowing expansion of the stent and pulls the stent into the stent sheath whereby a circumferential edge of the stent sheath causes the stent to contract as the stent spindle is raised.
A punch control element 408 includes a punch dial 450 attached to a proximal end of a reversely-threaded punch spindle 448, a punch receptacle 446 with an inner cylindrical area 444 open at a proximal end and threaded to accept the punch spindle, wherein the punch receptacle contains a centered coaxial hole to allow the primary tube 416 to pass through and attach to the punch spindle. The punch dial 450 is configured to turn either clockwise or counterclockwise to raise or depress the punch spindle 448 within the inner cylindrical area 444 of the punch receptacle 446, which raises and lowers the male element 412 via the primary tube 416 relative to the female element 420.
The punch 402 can be made of medical grade plastics or metals, as typically used in similar invasive surgical devices. At least the male element 412 has a cutting edge 414 used to perforate an aortic leaflet or other biological tissue. The cutting edge 414 is typically located around a circumference of the male element 412, and can be shaped in different manners, including, but not limited to, a uniform circle about a plane, a plurality of teeth in sine, square, triangle, or sawtooth pattern, or similar orientation.
The female element 420 can also have a cutting element 418 patterned to accepted the pattern of the male cutting element 414 to allow a fusiform punch 402 during insert of the device 400 through either the body and heart and into the aortic valve without snaring or otherwise inadvertently damaging tissue during insertion or positioning of the device. The female element 420 may likewise contain a receptacle for accepting the male cutting element 414.
The tip 410 may be conically shaped to pierce at least the wall of the aorta or femoral artery and allow entry of the device 400 into the aorta and aortic valve. Alternatively, the tip 410 may be flattened with sufficiently rounded edges to prevent damage to tissue during insertion or removal of the device from the body.
The primary 416, secondary 422, tertiary 430, and quaternary 432 tubes can be made from medical grade plastics, metals, or combinations thereof. There is no set length for any of the tubes 416, 422, 430 and 432. However, the primary tube 416 is necessarily longer that the secondary tube 422, and the tertiary tube 430 is necessarily longer than the quaternary tube 432. All four tubes 416, 422, 430 and 432 should be long enough to comfortably allow the insertion and positioning of the stent system 404 and punch 402 in the aorta and aortic valve, while simultaneously allowing a user to operate the punch control element 408 and the stent control element 406.
The punch control element 408 can be made from medical grade plastics, metals, or combinations thereof. The punch spindle 448 is preferably reversely-threaded and the inner cylindrical area 444 is preferably threaded to accept and secure the reversely-threaded punch spindle. However, a less preferable interaction between the punch spindle 448 and cylindrical area 444 involves the punch spindle slidably engaging the cylindrical area and frictional forces from a rubber ring or equivalent formed around the punch spindle maintaining the punch spindle position within the cylindrical area. The punch dial 450 need not be of any specific shape or size, but sized and shaped to allow a user to manipulate the punch 402 via the primary tube 416, punch spindle 448, and punch control element 408, generally.
The stent control element 406 can be made from medical grade plastics, metals, or combinations thereof. The stent spindle 440 is preferably reversely-threaded and the inner cylindrical area 438 is preferably threaded to accept and secure the reversely-threaded punch spindle. However, a less preferable interaction between the stent spindle 440 and cylindrical area 438 involves the stent spindle slidably engaging the cylindrical area and frictional forces from a rubber ring or equivalent formed around the stent spindle maintaining the stent spindle position within the cylindrical area. The stent dial 442 need not be of any specific shape or size, but sized and shaped to allow a user to manipulate the stent sheath 432 via the tertiary tube 430, stent spindle 440, and stent control element 406, generally.